¸ð±¸ÇüÁú¼¼Æ÷¾ç¼öÁö»ó¼¼Æ÷Á¾¾ç(BPDCN)½ÃÀå : ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼­-Ä¡·áº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°-½ÃÀå ¿¹Ãø(2025-2034³â)
Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size, Share, Trends, Industry Analysis Report: By Treatment, End Users, and Region - Market Forecast, 2025-2034
»óǰÄÚµå : 1605886
¸®¼­Ä¡»ç : Polaris Market Research
¹ßÇàÀÏ : 2024³â 11¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 118 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,250 £Ü 5,986,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,250 £Ü 7,394,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ 20¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,250 £Ü 8,803,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Polaris Market ResearchÀÇ ÃÖ±Ù Á¶»ç¿¡ µû¸£¸é, ¸ð±¸ÇüÁú¼¼Æ÷¾ç¼öÁö»ó¼¼Æ÷Á¾¾ç(BPDCN) ½ÃÀå ±Ô¸ð´Â 2034³â±îÁö 2,828¾ï 1,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Á¶»ç º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇÐÀ» ÀÚ¼¼ÇÑ ³»¿ëÀ» ÆÄ¾ÇÇÏ¿©, ¹Ì·¡ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

¸ð±¸ÇüÁú¼¼Æ÷¾ç¼öÁö»ó¼¼Æ÷Á¾¾ç(BPDCN) ½ÃÀåÀº ÀÌ Áúº´¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡¿Í Ä¡·á ¿É¼ÇÀÇ Áøº¸·Î Å« ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ÃËÁø ¿äÀÎÀ¸·Î´Â BPDCNÀÇ ÀÌȯÀ² »ó½Â, ½Å±Ô ¾àÁ¦³ª ¸é¿ª Ä¡·á µî Ç¥Àû Ä¡·á ¹× Çõ½ÅÀûÀÎ Ä¡·á¹ý °³¹ß µîÀÌ ²ÅÈ÷¸ç À̵éÀº Ä¡·á Àü¸ÁÀ» ³ÐÈ÷°í ÀÖ½À´Ï´Ù.

½ÃÀå ±âȸ´Â ȯÀÚÀÇ °á°ú¸¦ °³¼±ÇÏ´Â °ÍÀ» ¸ñÇ¥·Î ÇÏ´Â ÁøÇà ÁßÀÎ Á¶»ç¿Í ÀÓ»ó½ÃÇè, ¸ÂÃãÇü ÀÇ·á Á¢±Ù¹ýÀÇ µµÀÔ¿¡ ÀÇÇØ Áö¿øµÇ°í ÀÖ½À´Ï´Ù. Á¶±â Áø´Ü Áß½ÃÀÇ °íÁ¶³ª Â÷¼¼´ë ½ÃÄö¼­ ±â¼úÀÇ ÅëÇÕÀ̶ó´Â µ¿Çâµµ ½ÃÀåÀ» Çü¼ºÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Àü¹ÝÀûÀ¸·Î BPDCN ½ÃÀåÀº Ä¡·á ¼±ÅÃÁö °³¼±°ú ȯÀÚ Äɾî Çâ»ó¿¡ ÃÊÁ¡À» ¸ÂÃá ÀÌ·¯ÇÑ ¿äÀεé·Î ÀÎÇØ Å©°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ð±¸ÇüÁú¼¼Æ÷¾ç¼öÁö»ó¼¼Æ÷Á¾¾ç(BPDCN) ½ÃÀå º¸°í¼­ ¹× ÇÏÀ̶óÀÌÆ®

Ä¡·á ºÐ¼®º°·Î, ¸é¿ª Ä¡·á°¡ BPDCN ½ÃÀå¿¡¼­ °¡Àå ±Þ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. À̴ ǥÀûÄ¡·áÁ¦³ª üũÆ÷ÀÎÆ® ÀúÇØÁ¦ÀÇ Áøº¸·Î BPDCN Ä¡·á¿¡ ÀÖ¾î À¯¸ÁÇÑ °á°ú¸¦ ¾ò°í Àֱ⠶§¹®ÀÔ´Ï´Ù. ¸é¿ªÄ¡·á´Â ±× À¯È¿¼º°ú ºÎÀÛ¿ëÀÇ °æ°¨À¸·Î ÀÎÇØ ±âÁ¸ÀÇ È­ÇÐÄ¡·áº¸´Ù Á¡Á¡ ¼±È£µÇ°í ÀÖ½À´Ï´Ù.

ÃÖÁ¾ »ç¿ëÀÚº° ºÐ¼®À» ÅëÇØ °í±Þ ÀÎÇÁ¶ó¿Í Á¾ÇÕÀûÀÎ Ä¡·á ´É·ÂÀ¸·Î º´¿ø ºÎ¹®ÀÌ BPDCN Ä¡·á ½ÃÀåÀ» µ¶Á¡ÇÕ´Ï´Ù. Àü¹® Ŭ¸®´Ðµµ º¸´Ù ÁýÁßÀûÀÎ Ä¡·á¿¡ ´ëÇÑ µ¿ÇâÀ» ¹Ý¿µÇÏ¿© Àü¹®ÀûÀÎ Ä¡·á¿Í ȯÀÚ °ü¸®¸¦ Á¦°øÇÔÀ¸·Î½á ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù.

ºÏ¹Ì´Â ¿©ÀüÈ÷ BPDCNÀÇ ÃÖ´ë ½ÃÀåÀ̸ç, ÷´Ü °Ç°­ °ü¸® ÀÎÇÁ¶ó¿Í ³ôÀº ¿¬±¸ Ȱµ¿À» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ¾Æ½Ã¾Æ ÅÂÆò¾ç Áö¿ªÀº ÇコÄɾ ´ëÇÑ ÅõÀÚ Áõ°¡¿Í BPDCN¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ °¡Àå ºü¸£°Ô ¼ºÀåÇϰí ÀÖ´Â Áö¿ªÀÔ´Ï´Ù.

BPDCN ½ÃÀå¿¡ Àû±ØÀûÀ¸·Î Âü¿©Çϰí ÀÖ´Â ÁÖ¿ä ±â¾÷À¸·Î´Â Stemline Therapeutics»ç(ÇöÀç´Â Menarini Group »êÇÏ), Celgene Corporation»ç(Bristol-Myers Squibb°¡ Àμö), Pfizer Inc., Johnson &Johnson»ç, Novartis AG, Takeda Pharmaceutical, Amgen Inc., Gilead Sciences, F. Hoffmann-La Roche Ltd., Merck & Co., Inc., AbbVie Inc., AstraZeneca, Sanofi, Bayer AG, Incyte Corporation µîÀÌ ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°èÀÇ ¸ð±¸ÇüÁú¼¼Æ÷¾ç¼öÁö»ó¼¼Æ÷Á¾¾ç(BPDCN) ½ÃÀå ÀλçÀÌÆ®

Á¦5Àå ¼¼°èÀÇ ¸ð±¸ÇüÁú¼¼Æ÷¾ç¼öÁö»ó¼¼Æ÷Á¾¾ç(BPDCN) ½ÃÀå : Ä¡·áº°

Á¦6Àå ¼¼°èÀÇ ¸ð±¸ÇüÁú¼¼Æ÷¾ç¼öÁö»ó¼¼Æ÷Á¾¾ç(BPDCN) ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

Á¦7Àå ¼¼°èÀÇ ¸ð±¸ÇüÁú¼¼Æ÷¾ç¼öÁö»ó¼¼Æ÷Á¾¾ç(BPDCN)½ÃÀå : Áö¿ªº°

Á¦8Àå °æÀï ±¸µµ

Á¦9Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

AJY
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The blastic plasmacytoid dendritic cell neoplasm market size is expected to reach USD 282.81 billion by 2034, according to a new study by Polaris Market Research. The report "Blastic Plasmacytoid Dendritic Cell Neoplasm Market Size, Share, Trends, Industry Analysis Report: By Treatment (Chemotherapy, Immunotherapy, and Stem Cell Transplantation), End Users, Region (North America, Europe, Asia Pacific, Latin America and the Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The blastic plasmacytoid dendritic cell neoplasm market is experiencing significant growth driven by increasing awareness of the disease and advancements in treatment options. Key drivers include the rising incidence of BPDCN and the development of targeted therapies and innovative treatments, such as novel drugs and immunotherapies, which are expanding the treatment landscape.

Opportunities in the market are supported by ongoing research and clinical trials aimed at improving patient outcomes and the introduction of personalized medicine approaches. Trends such as the growing emphasis on early diagnosis and the integration of next-generation sequencing techniques are also expected to shape the market. Overall, the BPDCN market is expected to grow substantially due to these factors, with a focus on improving therapeutic options and enhancing patient care.

Blastic Plasmacytoid Dendritic Cell Neoplasm Market Report Highlights

By treatment analysis, immunotherapy is the most rapidly growing segment in the BPDCN market. This is due to its promising outcomes in BPDCN treatment, driven by advancements in targeted therapies and checkpoint inhibitors. Immunotherapy is being increasingly preferred over traditional chemotherapy due to its efficacy and reduced side effects.

By end users analysis, the hospital segment dominates the market for BPDCN treatments, owing to their advanced infrastructure and comprehensive care capabilities. Specialty clinics are also seeing growth as they offer specialized treatments and patient management, reflecting a trend toward more focused care.

North America remains the largest market for BPDCN, supported by advanced healthcare infrastructure and high research activity. However, Asia Pacific is the fastest-growing region, driven by increasing investments in healthcare and rising awareness of BPDCN.

Major players actively participating in the BPDCN market include Stemline Therapeutics (now part of Menarini Group); Celgene Corporation (acquired by Bristol-Myers Squibb); Pfizer Inc., Johnson & Johnson; Novartis AG; Takeda Pharmaceutical Company Limited; Amgen Inc.; Gilead Sciences; F. Hoffmann-La Roche Ltd; Merck & Co., Inc.; AbbVie Inc.; AstraZeneca; Sanofi; Bayer AG; and Incyte Corporation.

Polaris market research has segmented the blastic plasmacytoid dendritic cell neoplasm market report based on treatment, end users, and region:

By Treatment Outlook (Revenue - USD Billion, 2020-2034)

By End Users Outlook (Revenue - USD Billion, 2020-2034)

By Regional Outlook (Revenue - USD Billion, 2020-2034)

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market Insights

5. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Treatment

6. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by End Use

7. Global Blastic Plasmacytoid Dendritic Cell Neoplasm Market, by Geography

8. Competitive Landscape

9. Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â